Arcutis Biotherapeutics Secures $225 Million In Non-Dilutive Debt Financing From Slr Capital Partners
Amount Raised
$225 Million
Round Type
Debt Financing
Westlake VillageBiotechnologyHealth CareMedicalTherapeuticsDescription
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that it has obtained a $225 million term loan facility from funds managed by SLR Capital Partners (“SLR”). This additional capital further strengthens Arcutis’ balance sheet in advance of a potential 2022 Food and Drug Administration (FDA) approval and launch of topical roflumilast cream in plaque psoriasis, and in advance of three 2022 pivotal clinical data readouts in atopic dermatitis, seborrheic dermatitis, and scalp psoriasis. This non-dilutive financing commitment extends the Company’s cash runway into 2024.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as Arcutis that raised within 45 days of this round, from Fundz verified event records.
- Faeth Therapeutics raised $20M (Seed) on January 18, 2022.
- Acrivon Therapeutics raised $100M on November 23, 2021.
- Compugen raised $20M on November 22, 2021.
- Acrivon Therapeutics raised $100M (Series B) on November 11, 2021.
- MindImmune Therapeutics raised $5.3M on February 4, 2022.
- Passage Bio raised $4M (Seed) on February 1, 2022.
Who to call at Arcutis, and when
A new round usually means Arcutis is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Arcutis raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Arcutis, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Arcutis. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Arcutis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Arcutis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.